The pharmaceutical service provider Vetter Pharma has successfully completed eight market launches of complex medicinal products in 2023. The products were accompanied and supported during their development phases by the comprehensive services of the Vetter Development Service. The drugs, which are now on the market...
As a globally active Contract Development and Manufacturing Organization (CDMO), Vetter has joined the German Association of Research-Based Pharmaceutical Companies vfa as an associate member. With this special membership, the vfa recognizes the significant role that the pharmaceutical service provider plays in the...
Vetter has been a member of the Science Based Targets Initiative (SBTi) since November 2023. The aim of the companies in the SBTi is to become climate-neutral by 2050. The initiative thus represents the strictest climate protection targets for companies worldwide. The pharmaceutical service provider has thus committed...
The pharmaceutical service provider Vetter is investing over 230 million euros in a new production building at its Ravensburg site, which will house several commercial filling lines. With the completion of the 122-meter-long, 44-meter-wide and 32-meter-high shell, an important milestone has now been reached following...
Vetter, a leading global Contract Development and Manufacturing Organization (CDMO), has been awarded the Frost & Sullivan’s 2023 Global Customer Value Leadership Award in the aseptic fill-and-finish market for the company’s high performance for its customers. The award, presented annually by the international...
Vetter, a globally leading contract development and manufacturing organization (CDMO), announced the commissioning of a new warehouse designed to help meet increasing customer market supply demands. With a total investment of approx. 20 million euros, the new fully automated building provides storage space for...
With the realization of the first successful customer fills, Vetter, a leading global Contract Development and Manufacturing Organization (CDMO), has reached another milestone at its new clinical manufacturing facility in Rankweil, Austria. Further batches are already planned, and more customer projects are in the...
For the third year in a row, Vetter, a globally leading contract development and manufacturing organization (CDMO), has won the Best Managed Companies Award. With this three-win feat, the pharmaceutical service provider has once again demonstrated why it is considered one of the industry leaders. The awards committee...
Vetter, a global leading contract development and manufacturing organization (CDMO), successfully participated in a lab benchmarking with its incoming goods lab in the past year. The University of St. Gallen (HSG) participated in the project as a scientific partner. This educational institution not only offers a wealth...
Vetter has received the manufacturing authorization for its new site in Rankweil, Austria. As a result of the successful inspection held by the responsible national regulatory authority, the Austrian Agency for Health and Food Safety (Ages), the site can now support clinical development projects of international...
